Ahead of Alzheimer’s stands at the forefront of a new era, one where brain health and wellness become a national priority, early detection becomes standard, and Alzheimer’s is no longer a passive diagnosis, but an active, manageable condition. Our show brings together patients, families, caregivers, clinicians, researchers, policymakers, and thought leaders to explore the science, stories, breakthroughs, and policy conversations that can help people understand risk, recognize possibility, and act sooner. In this episode, Emily Kaplan speaks with Dr. Robert Redfield, former Director of the Centers for Disease Control and Prevention, about why early diagnosis has changed the course of other major diseases and why Alzheimer’s should not be treated differently. Drawing from his work during the AIDS crisis, Dr. Redfield explains how routine testing helped drive research, treatment, and public health action. He makes the case for bringing Alzheimer’s testing into everyday medical care, while also addressing access to FDA-approved treatments and Medicare coverage barriers. Watch the episode to hear Dr. Redfield’s perspective on why early diagnosis is a fundamental principle of medicine and what it could mean for the future of Alzheimer’s care.